Academician
SEMA YILMAZ
PROFESÖR
SELÇUK ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Romatoloji
Article counts come from two sources, each shown separately: YÖKSİS (academic declarations) and OpenAlex (open scholarly catalog). Patents and artistic activities are listed under the Works tabs below.
Index quartiles
Scopus (SJR)
51 Total
- Q1 16
- Q2 22
- Q3 9
- Q4 4
Other counts
- YÖKSİS rows 52 Q1 0 Q2 0 Q3 0 Q4 0
WoS (JCR)
54 Total
- Q1 9
- Q2 14
- Q3 20
- Q4 12
Other counts
- Best Q 54 Q1 9 Q2 14 Q3 19 Q4 12
- YÖKSİS rows 56 Q1 0 Q2 0 Q3 0 Q4 0
TR Index
12 articles
Other counts
- YÖKSİS rows 13 articles
OpenAlex citation percentiles
OpenAlex citation percentile; covered works only (~52%).
What do these indicators mean?
- Q1–Q4: the quartile of the journal in the given index (Scopus/WoS). Q1 = top 25%, Q4 = bottom 25%.
- Top 1% / top 10%: number of works among the top 1% or 10% most-cited worldwide in the same field and year.
- Avg percentile: mean citation percentile of the works (100 = highest).
- Source: index quartiles from Scopus/WoS and TR Index flags; citation percentiles from OpenAlex.
Proceedings
Conference proceedings recorded in YÖKSİS.
Records
- 2018 The Efffect of Family History on Disease Phenotypes in 1393 Psoriatic Arthritis Patients
- 2016 DAPSA 28 May Be Used Instead Of DAPSA 66 68 in Psoriatic Arthritis
- 2019 The Efficacy and Safety of Anti-TNF Alfa Treatment in Ankylosing Spondylitis Patients with Late Onset Compared to Those with Adult Onset The Data From TURKBIO Registry
- 2020 Demographic and Clinical Features of Juvenile-onset Psoriatic Arthritis: Results from PsART-ID Registry
- 2020 Methotrexate Survival Rate in Patients with Psoriatic Arthritis from Psoriatic Arthritis International Database (PsArt-ID) Cohort
- 2019 Remission and Drug Retention Rates of Secukinumab in 1549 patients with Psoriatic Arthritis Treated in Routine Care– Pooled Data from the Observational EuroSpA Research Collaboration Network
- 2022 Incidence of Anterior Uveitis in Axial Spondyloarthritis during Secukinumab Treatment: TWO YEARS REAL LIFE EXPERIENCE FROM TURKBIO REGISTRY
- 2020 THU0378 DO COMORBIDITIES DECREASE THE FIRST TNF-INHIBITOR RETENTION AND TREATMENT RESPONSE IN AXIAL SPONDYLOARTHRITIS PATIENTS? DATA FROM TURKBIO
- 2020 Disease Characteristics of Psoriatic Arthritis Patients May Differ According to Age at Psoriasis Onset: Cross-sectional Analysis of Psoriatic Arthritis- International Database,
- 2019 Secukinumab Effectiveness in 1134 Patients with Psoriatic Arthritis Treated in Routine Clinical Practice in 11 European Countries in the EuroSpA Research Collaboration Network
- 2018 The Treatment Choices and Response for a Psoriatic Arthritis Inception Cohort
- 2024 Impact of Extra-Articular Manifestations on Biological Treatment Choice in Axial Spondyloarthritis Patients:Real-World Data from TURKBIO
- Relationship of Klotho and Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients
- The Efficacy and Safety of CT-P13 as First-line and Subsequent–line Therapy in Patients with Anklylosing Spondylitis: Real-Life Data from TURKBIO Cohort,
- 2019 Current Smoking Status Increaes the Risk of Axial Psoriatic Arthritis: An Explanation to Smoking Paradox
- 2018 Impact of Obesity on Drug Survival of Tofacitinib in Patients with Rheumatoid Arthritis: Analysis from Turkbio Registry
- Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort
- Disease Duration and HLA-B27 Positivity Alter Longterm Retention Rate of Certolizumab Pegol in Paients with Psoriatic Arthritis
- 2020 Are There Any Differencies Between Adult-Onset Rheumatoid Arthritis and Late-Onset Rheumatoid Arthritis Patients in Terms of Use of Biological Drugs and Drug Retention Rate?
- 2019 The Efficacy and Safety of Anti-TNF Treatment in Ankylosing Spondylitis Patients with Late Onset Compared to Those with Adult Onset The Data from TURKBIO Registry